What the Wegovy and Ozempic labels say about a missed dose
The first question after a missed injection is: can the dose still be taken? The answer depends on which semaglutide medication has been prescribed, because the US FDA prescribing information for each product uses a different timing window.
The Wegovy (semaglutide injection for weight management) US FDA prescribing information states that a missed dose should be administered as soon as possible, but only when the next scheduled dose is more than 2 days (48 hours) away. If the next dose is less than 48 hours away, the missed dose should be skipped entirely.
The Ozempic (semaglutide injection for type 2 diabetes) US FDA prescribing information uses a longer window: take the missed dose as soon as possible, within 5 days of the missed injection. If more than 5 days have passed, skip it.
In both cases, the next scheduled injection day stays the same. Neither label recommends shortening the interval or taking two doses to compensate.
| Medication | Indication | Take missed dose if | Skip the dose if | Next scheduled dose |
|---|---|---|---|---|
| Wegovy (semaglutide 2.4 mg) | Weight management | Next dose is more than 48 hours away | Next dose is 48 hours away or less | Same day of the week; do not shift the calendar |
| Ozempic (semaglutide 0.5, 1, or 2 mg) | Type 2 diabetes | Within 5 days of the missed dose | More than 5 days have passed | Same day of the week; do not shift the calendar |
People using compounded semaglutide through a telehealth provider should follow the specific instructions included with their pharmacy's dispensed medication rather than applying either label above. Compounded semaglutide is not FDA-approved and does not carry an FDA-reviewed prescribing label; the dispensing pharmacy and prescribing provider are the authoritative sources for dosing guidance on compounded formulations.
Why semaglutide's long half-life cushions a missed dose
A drug's half-life is the time it takes for blood concentrations to fall by half. Semaglutide's half-life is approximately 160 hours (roughly 7 days), which is what makes once-weekly dosing practical, and what makes a single missed injection less disruptive than it might feel. This long half-life results from a fatty acid side chain that lets semaglutide bind reversibly to albumin in the bloodstream, slowing its breakdown and renal clearance, as documented in peer-reviewed pharmacokinetics research published in Clinical Pharmacokinetics.
What that means in practice: by the day the missed dose was supposed to arrive, roughly half of the previous week's dose is still circulating. Two weeks after the last injection, about 25 percent remains. The drug does not vanish overnight the way a short-acting medication would.
According to a 2024 systematic review of semaglutide pharmacokinetics, steady-state concentrations (the point at which drug levels stabilize from week to week) are reached after approximately 4 to 5 weeks of consistent weekly dosing. Once at steady state, the buffer of accumulated drug makes a single missed dose even less pharmacologically significant than the same miss would be at the very start of treatment.
This does not mean skipping doses is harmless long-term. Consistent weekly dosing is how the medication maintains its effects. But one missed injection, pharmacologically, is not the crisis the anxiety around it often suggests.
What you may actually notice after a missed injection
Even with levels declining gradually, changes in appetite and digestion can become noticeable within days of a missed dose. Semaglutide reduces appetite partly by slowing gastric emptying and partly by acting on satiety signals in the brain. As drug levels drift lower, both effects soften.
Some people find that food becomes more appealing and portion sizes feel larger than they have in weeks. Mild hunger between meals may return. These are expected physiological responses, not signs that treatment has failed or that progress will be lost.
Meaningful weight regain from one missed dose is unlikely. Body weight fluctuates by several pounds from day to day due to fluid shifts, sodium intake, and digestive timing. The STEP 1 trial, which studied Wegovy (semaglutide 2.4 mg) in adults with obesity over 68 weeks, found a mean weight loss of 14.9 percent in the treatment group, driven by sustained, consistent dosing over the full trial period. Compounded semaglutide has not been evaluated in equivalent clinical trials and is not FDA-approved. A single gap in the schedule is unlikely to produce a clinically significant setback when the overall treatment course is maintained.
For a fuller picture of how effects build and shift over months of treatment, the article on what to expect in your first 90 days on a GLP-1 walks through the week-by-week progression in detail.
Why a double dose is always the wrong move
Both the Wegovy and Ozempic prescribing labels are explicit: do not administer two doses to compensate for a missed one. This is not caution for its own sake. It reflects a direct pharmacological risk.
Semaglutide's most common side effects, primarily nausea, vomiting, and abdominal discomfort, are dose-dependent. Higher peak concentrations raise both the likelihood and severity of gastrointestinal symptoms. The entire rationale for the slow escalation schedule at the start of treatment (beginning at 0.25 mg and increasing every four weeks, per the Wegovy prescribing information) is to let the body build tolerance gradually. Stacking two doses in a short window recreates exactly the kind of rapid peak exposure the escalation schedule is designed to avoid.
Doubling up also disrupts the weekly calendar. If a missed dose is taken and then the next regular dose follows only days later, the effective dosing interval shrinks dramatically, compressing two weeks of exposure into a few days.
The correct response in every scenario is to return to the original weekly schedule. If the window for taking the missed dose has closed, that week is simply skipped, and the next injection falls on the usual scheduled day. Recovering lost momentum happens through consistent dosing going forward, not through extra doses.
What to do after missing two or more consecutive doses
Missing two or more injections in a row deserves more attention than a single skipped dose. After two weeks without semaglutide, concentrations have fallen to roughly 25 percent of steady-state. After three weeks, levels approach those seen during the very first weeks of treatment, before any meaningful accumulation occurred.
The Wegovy prescribing information addresses this directly: if two or more consecutive doses are missed, patients should resume dosing as scheduled or, if needed, reinitiate Wegovy by following the dose escalation schedule. The escalation option exists because gastrointestinal tolerance built during the initial titration period can diminish during an extended break. Returning to a maintenance dose (such as 1.7 mg or 2.4 mg) after a two-week gap may feel the same as starting at that dose on day one, with renewed nausea and discomfort.
How long a gap actually requires re-titration varies by individual and by the dose the patient was taking when the gap began. Providers generally evaluate the break length, the patient's prior tolerance history, and any medical circumstances that contributed to the gap before recommending an approach. This is a conversation for the prescribing clinician rather than a self-directed decision.
For context on what stopping entirely means for the body, the article on what happens when you stop taking a GLP-1 medication covers weight changes and appetite rebound in detail.
What re-titration looks like in practice
Re-titration means restarting the dose escalation schedule from a lower starting point rather than jumping back to the maintenance dose after a break. For Wegovy, the standard escalation begins at 0.25 mg once weekly for four weeks, then advances by 0.25 mg every four weeks, as described in the Wegovy prescribing information.
In practice, a provider may recommend a full restart from 0.25 mg, a partial step-down (returning to one or two steps below the previous maintenance dose), or simply resuming at the current dose if the break was short and prior tolerance was strong. The right approach is individual.
The risk of skipping re-titration is not abstract. The Wegovy prescribing information includes the re-escalation option precisely because gastrointestinal tolerance built during initial titration can diminish during an extended break, raising the risk of side effects significant enough to interrupt treatment again if a full maintenance dose is resumed without stepping down. Re-titration is a safety protocol, not a penalty for missed doses.
Readers who want to understand how weight loss momentum builds and what normal progress looks like may find the article on how fast semaglutide works useful for framing expectations after any restart.
Practical strategies for preventing missed doses
Because the consequences of inconsistency accumulate, preventing missed doses is more effective than recovering from them. A few straightforward strategies reduce the risk significantly.
- Anchor the injection to a fixed weekly event. Linking the injection day to a routine that already happens reliably each week (Sunday evening, Monday morning) reduces the cognitive effort of remembering. The environmental cue does much of the work.
- Set two phone reminders. One alert 24 hours before the injection day and one on the day itself creates a two-layer safety net against busy or disrupted weeks.
- Order refills early. Running out of medication is one of the most common causes of unplanned gaps. Ordering the next supply as soon as the current one arrives protects against pharmacy and shipping delays.
- Designate a consistent injection time of day. Dosing at the same time each week makes it easier to notice if that time passes without the injection occurring.
- Plan around known disruptions. If a scheduled surgery, procedure, or trip is likely to interfere with a dose, discussing it with the prescribing provider in advance allows for a coordinated plan rather than a reactive one.
Nutrition consistency also supports steady treatment results. The article on what to eat while taking semaglutide covers how food choices interact with the medication and how to maintain appetite-supporting habits through schedule disruptions.
Traveling without missing a dose
Travel is one of the most common triggers for missed or delayed semaglutide doses. Three distinct issues come into play: medication storage, airport security, and time-zone scheduling.
Storage requirements on the road: Semaglutide requires refrigeration at 36 to 46 degrees Fahrenheit (2 to 8 degrees Celsius) when not in active use. An in-use Ozempic pen can be kept at room temperature (59 to 86 degrees Fahrenheit) for up to 56 days. An unopened Wegovy pen can be stored unrefrigerated for up to 28 days. These rules apply to the named FDA-approved products; compounded semaglutide storage requirements are set by the dispensing pharmacy and should be followed as instructed. Never freeze any semaglutide formulation.
Airport security: Injectable medications are exempt from the TSA liquid restriction and do not need to fit inside a quart-sized bag. Traveling with the original pharmacy label or a prescription receipt reduces questions at screening. Keep the medication in carry-on luggage: aircraft cargo holds can reach temperatures cold enough to freeze and degrade semaglutide.
Time zones: Crossing multiple time zones shifts the local date without changing the injection interval. Before a trip spanning more than a few hours' difference, ask the prescribing provider whether to keep the original calendar day or adjust for the destination time zone. Most providers recommend keeping a consistent weekly interval rather than chasing a specific local time of day.
Evaporative cooling pouches (such as Frio-brand pouches, which activate with water) can maintain the required temperature range for 48 hours or more without electricity, making them practical for transit days and locations without reliable refrigeration.
When to contact your provider before resuming
Most single missed doses can be managed straightforwardly using the label rule for the prescribed medication. Some situations, however, call for guidance from the prescribing provider before resuming.
- Two or more consecutive doses have been missed and there is uncertainty about whether to resume at the current dose or step down.
- A gap of three weeks or more has occurred, since full or partial re-titration is very likely needed at that point.
- Nausea or vomiting was significant at the current maintenance dose before the gap. Returning to that dose without provider guidance after a break raises the risk of a difficult reaction.
- The break followed a medical event such as surgery, hospitalization, or an illness requiring medication changes. The provider can determine whether those circumstances affect how to safely restart.
- Medication supply is running low and the gap may extend further. A planned gap can sometimes be managed differently than an accidental one.
Providers handling GLP-1 prescriptions routinely field calls and messages about missed doses; most have a clear protocol for these situations. Reaching out early is almost always easier than managing a difficult reaction from a dose resumed improperly.
If overall weight loss has stalled before or after any break, the article on why weight loss may stall on semaglutide covers the factors beyond missed doses that affect individual response.